These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

685 related items for PubMed ID: 14745850

  • 1. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M, Noda S, Yamazaki S, Kakishima H, Yamasaki K, Kimber I.
    J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
    [Abstract] [Full Text] [Related]

  • 2. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M, Iida K, Shiraishi K, Hoshuyama S.
    J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
    [Abstract] [Full Text] [Related]

  • 3. Contact allergenic potency: correlation of human and local lymph node assay data.
    Gerberick GF, Robinson MK, Ryan CA, Dearman RJ, Kimber I, Basketter DA, Wright Z, Marks JG.
    Am J Contact Dermat; 2001 Sep; 12(3):156-61. PubMed ID: 11526521
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Quantitative relationship between the local lymph node assay and human skin sensitization assays.
    Schneider K, Akkan Z.
    Regul Toxicol Pharmacol; 2004 Jun; 39(3):245-55. PubMed ID: 15135206
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. ICCVAM evaluation of the murine local lymph node assay. Data analyses completed by the National Toxicology Program Interagency Center for the Evaluation of Alternative Toxicological Methods.
    Haneke KE, Tice RR, Carson BL, Margolin BH, Stokes WS.
    Regul Toxicol Pharmacol; 2001 Dec; 34(3):274-86. PubMed ID: 11754531
    [Abstract] [Full Text] [Related]

  • 14. The local lymph node assay and the assessment of relative potency: status of validation.
    Basketter DA, Gerberick F, Kimber I.
    Contact Dermatitis; 2007 Aug; 57(2):70-5. PubMed ID: 17627643
    [Abstract] [Full Text] [Related]

  • 15. Estimation of relative skin sensitizing potency using the local lymph node assay: a comparison of formaldehyde with glutaraldehyde.
    Hilton J, Dearman RJ, Harvey P, Evans P, Basketter DA, Kimber I.
    Am J Contact Dermat; 1998 Mar; 9(1):29-33. PubMed ID: 9471984
    [Abstract] [Full Text] [Related]

  • 16. The impact of vehicle on assessment of relative skin sensitization potency of 1,4-dihydroquinone in the local lymph node assay.
    Lea LJ, Warbrick EV, Dearman RJ, Kimber I, Basketter DA.
    Am J Contact Dermat; 1999 Dec; 10(4):213-8. PubMed ID: 10594297
    [Abstract] [Full Text] [Related]

  • 17. The local lymph node assay and skin sensitization testing.
    Kimber I, Dearman RJ.
    Methods Mol Biol; 2010 Dec; 598():221-31. PubMed ID: 19967517
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Intra-laboratory study to determine the reproducibility of LLNA:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
    Chen W, Xing C, Hou F.
    J Pharmacol Toxicol Methods; 2016 Dec; 82():26-30. PubMed ID: 27456929
    [Abstract] [Full Text] [Related]

  • 20. The reduced local lymph node assay: the impact of group size.
    Ryan CA, Chaney JG, Kern PS, Patlewicz GY, Basketter DA, Betts CJ, Dearman RJ, Kimber I, Gerberick GF.
    J Appl Toxicol; 2008 May; 28(4):518-23. PubMed ID: 17879259
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.